|
|
Post by BD on Aug 10, 2015 8:55:12 GMT -5
pete, see my 2nd post in this thread above...
|
|
|
|
Post by BD on Aug 10, 2015 8:59:54 GMT -5
No position in MNKD just just following the saga. From what I understand from the comments of this board Matt asked Shareholders to not lend out their shares to shorts. Folks' very fundamentally there is one reason to buy stock and one reason to short a stock. You buy because you expect the stock to increase in price, you short a stock because you expect the stock price to decline. Matt is blaming poor PPS on Shorts, what a bunch of baloney! If Matt wants to increase PPS and decrease the short holdings how about pressuring SNY to do some real marketing, get the pricing competitive, get some insurance companies on board.... Matt should be ashamed of this cop-out and take ownership for the reasons of poor stock performance, there's a good reason why you've never heard shorts addressed in a conference call before, most presenters take accountability instead of blaming others. I think it's fantastic that Matt put out the call. How many times have you seen someone post, in response to general griping directed at those who lend out their shares, that "our positions won't make a dent"... well, Matt took the time in a quarterly CC to specifically bring the issue up. If that isn't saying that our petty retail positions getting lent out DOES matter, then I have no idea what it was saying. |
|
|
|
Post by tbone on Aug 10, 2015 9:02:23 GMT -5
No position in MNKD just just following the saga. From what I understand from the comments of this board Matt asked Shareholders to not lend out their shares to shorts. Folks' very fundamentally there is one reason to buy stock and one reason to short a stock. You buy because you expect the stock to increase in price, you short a stock because you expect the stock price to decline. Matt is blaming poor PPS on Shorts, what a bunch of baloney! If Matt wants to increase PPS and decrease the short holdings how about pressuring SNY to do some real marketing, get the pricing competitive, get some insurance companies on board.... Matt should be ashamed of this cop-out and take ownership for the reasons of poor stock performance, there's a good reason why you've never heard shorts addressed in a conference call before, most presenters take accountability instead of blaming others. He didn't blame shorts. He addressed the whining retail shareholder that asks, "what are you gonna do?" The answer was clear, it's a function of the market, not our problem, but you don't have to facilitate more of it. |
|
|
|
Post by lakefox333 on Aug 10, 2015 9:02:39 GMT -5
Matt is exactly correct!
|
|
|
|
Post by chicagpete on Aug 10, 2015 9:04:33 GMT -5
No position in MNKD just just following the saga. From what I understand from the comments of this board Matt asked Shareholders to not lend out their shares to shorts. Folks' very fundamentally there is one reason to buy stock and one reason to short a stock. You buy because you expect the stock to increase in price, you short a stock because you expect the stock price to decline. Matt is blaming poor PPS on Shorts, what a bunch of baloney! If Matt wants to increase PPS and decrease the short holdings how about pressuring SNY to do some real marketing, get the pricing competitive, get some insurance companies on board.... Matt should be ashamed of this cop-out and take ownership for the reasons of poor stock performance, there's a good reason why you've never heard shorts addressed in a conference call before, most presenters take accountability instead of blaming others. I think it's fantastic that Matt put out the call. How many times have you seen someone post, in response to general griping directed at those who lend out their shares, that "our positions won't make a dent"... well, Matt took the time in a quarterly CC to specifically bring the issue up. If that isn't saying that our petty retail positions getting lent out DOES matter, then I have no idea what it was saying. I just called schwab. Going through process to get my shares out of lending pool ASAP. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 10, 2015 9:05:51 GMT -5
Matt did a fantastic job of addressing MannKind shareholders concerns. If one is still not satisfied I suggest selling and move on.
|
|
|
|
Post by Chris-C on Aug 10, 2015 9:09:10 GMT -5
Overall, a decent call. I would have liked to hear more specifics about Sanofi's applications for approval abroad; but I'm reasonably confident the Europeans will have a recommendation before year's end. The next scheduled meeting of their Committee for Medicinal Products for Human Use is August 17-20. Matt made it clear that SNY is thinking globally, not just in Europe. Other highlights I liked about the call: • Appointment of new Chief Medical Officer to help facilitate the development of the new APIs • Clear signals that Matt pays close attention to retail investor's questions/comments/assertions (this was evident in his recent reply shared on the board) • Acknowledgment of the very complex (and market research informed) marketing effort by SNY • Great progress on the post approval studies required by the FDA (pediatric, dose range and intra subject variability; pulmonary safety study seems to be under negotiation with the FDA) • Acknowledgment that a 2 unit cartridge is under consideration and could be easily manufactured using existing production lines • Timetable (next 2-3 months) for introducing the 12 unit cartridges into the market • Acknowledgment that formulary approvals are the key impediment now and strategies are in place to address those • Reaffirmation of 175M credit facility for production expenses (of which only 28M has been used) • No question by Jay Olson of G-S suggesting a SNY bail out. (although, to me, his question about product shipment sounded like short bait-sorry I just don't like the weasel or the company he works for) • Affirmation of expansion of SNY physician target population and commitment of additional sales staff to the effort • Reiteration that samples continue to be provided, and that they are confident that marketing and sales efforts will begin to show up in larger script numbers Most of these topics have been discussed on this board; which reaffirmed my perception that this the best place on the Internet to remain informed about all things Afrezza and Mannkind. So far, the market seems to like what it heard. Regards to all longs (especially those who keep their shares in cash accounts).  Chris C |
|
|
|
Post by harryx1 on Aug 10, 2015 9:09:20 GMT -5
BRING HOME YOUR SHARES!!!!!!
|
|
|
|
Post by kc on Aug 10, 2015 9:10:17 GMT -5
I sent Matt a message last week that I didn't post with some of my comments and suggestions. He and Haken both responded separately and very professionally regarding an idea to give to the Joint committee. I did not comment or post the suggestion or their reply as I thought it a reply that should be keep privately. Sometimes we should not tell everything we know or hear as the Shorty's hear it to and use it against MannKind. So I can see why Management responds like they do to the public.
My take of today's call is that they are very busy working on Afrezza, new ideas and running the company for the future. I think that the resolution of the notes will be very interesting as the are issuing Non-registered shares to the new selected note holders. My suspicion is when the BA shares come back to MannKind into the treasury . Then these newly returned treasury shares will be reissued to the holders of the Non-registered shares and we will see Buy In? Yes! Buy In. |
|
|
|
Post by chicagpete on Aug 10, 2015 9:12:38 GMT -5
BRING HOME YOUR SHARES!!!!!! All my shares returned. Schwab rep warned me that it may be difficult to lend out again and/or get same interest rate. But I heard Matt loud and clear. Done lending |
|
|
|
Post by rch51 on Aug 10, 2015 9:13:40 GMT -5
No position in MNKD just just following the saga. From what I understand from the comments of this board Matt asked Shareholders to not lend out their shares to shorts. Folks' very fundamentally there is one reason to buy stock and one reason to short a stock. You buy because you expect the stock to increase in price, you short a stock because you expect the stock price to decline. Matt is blaming poor PPS on Shorts, what a bunch of baloney! If Matt wants to increase PPS and decrease the short holdings how about pressuring SNY to do some real marketing, get the pricing competitive, get some insurance companies on board.... Matt should be ashamed of this cop-out and take ownership for the reasons of poor stock performance, there's a good reason why you've never heard shorts addressed in a conference call before, most presenters take accountability instead of blaming others. Nonsense! Incessant stock manipulation and strategically timed short raids have been devastating to the pps. I don't see Matt's comments as anything other than a sober admission that negative market forces are aligned against us and we as lending longs are adding fuel to their bonfire. Sadly, when one has held for 5 to 10 years with a negative trading balance it's hard to give up the only real return on MNKD stock since it's inception. I'll pull my 70k shares back if everyone else does too. Otherwise, I'm just flushing money down the drain. |
|
|
|
Post by longstocking on Aug 10, 2015 9:15:23 GMT -5
BRING HOME YOUR SHARES!!!!!! Never lent them out and don't plan to. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 10, 2015 9:18:48 GMT -5
Matt confirms what I have been saying for months. Print and TV ads are not where it's at. It's online due to the vast majority of people who use the internet to search for info. As for longs lending their shares out to short. I say go for it. At least you'll make some money on the stock. Maybe if the company had its act together, shareholders wouldn't have to lend out their shares in the first place. Online far more targeted and capital efficient especially so for a new product. Not uncommon these days for patient to arrive at physicians office and be handed a tablet to check in or fill out paperwork (digital paperwork that is). In some cases, depending on visit / patient health condition they may see a targeted advertisement on the tablet. Doc gets some $$ for all this so a way for them to generate a bit of revenue and for Rx companies to get their product in front of patient right before they see their physician. Talk about targeting and timing. No TV ads for some time. It just wouldn't be financially prudent. Afrezza needs to have the burden of prior authorization significantly reduced. Interesting comments on the call from an analyst inquiring if MNKD feels impacted by large competitors trying to get exclusive formulary position i.e. big price cut to be only play on formulary. Lots of ways for SNY to effectively work around this. More and better data pertaining to A1c and hypo reductions and then comparing traditional RAA to Afrezza is no longer apples to apples. Mr. Insurance company, my product is priced 25% higher and for that investment, you get patient A1c lowered by XX%, incidences of hypoglycemia lowered by YY%, reduction in ER visits and LT health complications. Mr. Insurance company, the ROI on Afrezza is XXX% so from a pure economic perspective, your and your employer would be adversely impacting shareholder value by not paying a premium for Afrezza. |
|
|
|
Post by centralcoastinvestor on Aug 10, 2015 9:18:49 GMT -5
BRING HOME YOUR SHARES!!!!!! Sing it brother! We longs can and do a considerable amount of complaining about management. Well management just directed a complaint back to retail shareholders about something they can do. Stop lending your shares. We are cutting our own throats by lending. |
|
|
|
Post by newmnkdinvestor on Aug 10, 2015 9:21:32 GMT -5
Hmmmm... Matt appealing to shareholders to not allow their shares to be lent out. Perhaps the percentage of retail accounts responsible for the availability of shares to short is higher than we've been speculating it is... It has to be huge. Those who have enough to lend out are certainly not going to pass up. The other half have margin turned on. I turned off margin in hopes that I would get a call to lend out my shares but it never happened. So I had margined turned back on. I use margin more for unsettled cash if the opportunity presents itself vs taking a long position on margin. |
|
